甲基丙二酸血症相关脑积水的临床特征、手术时机与健康相关生活质量
该回顾性观察研究纳入2012年6月至2022年3月收治的1671例脑积水患者中的77例MMA相关脑积水病例,评估临床特征、手术数据及PedsQL™ 4.0量表测得的生活质量,以确定最佳手术时机。最常见突变为MMACHC基因c.609G>A(70%),66例(85.7%)行脑室腹腔分流术,其Evans指数高于非分流组(P<.001),Evans指数临界值为0.45。分流组中19例(24.7%)需翻修,翻修组药物治疗时间更短(P=.002)、手术年龄更小(P=.049),最佳临界点为药物治疗>1个月和手术年龄>4.5个月。
要点
- MMA相关脑积水最常见突变为MMACHC基因c.609G>A,占70%。
- Evans指数>0.45提示需手术,分流组Evans指数显著高于非分流组。
- 分流翻修与药物治疗≤1个月、手术年龄≤4.5个月相关。
核心结论
- 严重脑积水的MMA患者PedsQL™评分更低且需要手术。
- 最佳手术时机为Evans指数>0.45、药物治疗时间>1个月且手术年龄>4.5个月,以减少并发症并改善生活质量。
研究设计与样本
- 回顾性观察研究,纳入2012年6月至2022年3月收治的1671例脑积水患者中的77例MMA相关脑积水病例。
- 收集临床特征、手术数据,并使用PedsQL™ 4.0通用核心量表评估健康相关生活质量。
主要发现
- 最常见临床表现为发育迟缓、食欲差和意识改变。
- 最常见突变为MMACHC基因c.609G>A,占70%。
- 66例(85.7%)行脑室腹腔分流术,其Evans指数高于非分流组(P<.001)。
- 非分流组在所有PedsQL™维度得分均优于分流组。
- 66例分流患者中19例(24.7%)需翻修手术,翻修组药物治疗时间更短(P=.002)、手术年龄更小(P=.049)。
关键数值与推荐
- Evans指数临界值为0.45。
- 最佳手术时机临界点:药物治疗时间>1个月,手术年龄>4.5个月。
- 翻修组心理社会健康和学校功能得分更低。
临床怎么用
- 对MMA相关脑积水患者,当Evans指数>0.45、药物治疗>1个月且年龄>4.5个月时考虑手术,以降低翻修风险并改善生活质量。
局限性
- 回顾性观察研究设计。
- 样本量有限(77例)。
- 单中心数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Hydrocephalus is a rare and potentially fatal complication of methylmalonic acidemia (MMA) and is associated with a poor prognosis, requiring prompt clinical decision making. The aim of our study was to evaluate the clinical characteristics and quality of life of infants with hydrocephalus caused by MMA and to determine the optimal timing of surgery. METHODS: This is a retrospective observational study. We reviewed 77 MMA-related hydrocephalus cases from 1671 hydrocephalus patients admitted between June 2012 and March 2022. Data collected included clinical characteristics, surgical data, and health-related quality of life assessed using the Pediatric Quality of Life Inventory (PedsQL™) 4.0 generic core scales. RESULTS: The most common clinical manifestations were developmental retardation, poor appetite, and altered consciousness. The most frequent mutation was c.609G>A in MMACHC gene (70%). Sixty-six patients (85.7%) underwent ventriculoperitoneal shunting with higher Evans index than the non-VPS group ( P < .001). An Evans index cutoff point of 0.45 was identified. The non-VPS group scored better on all PedsQL™ domains. Of the 66 cases in the ventriculoperitoneal shunting group, 19 (24.7%) needed revision surgery. They had a shorter duration of drug treatment ( P = .002) and underwent surgery at a younger age ( P = .049) than those in the nonrevision group. Optimal cutoff points were duration of drug treatment >1 month and age of surgical treatment >4.5 months. The revision group had lower psychosocial health and school functional scores. CONCLUSION: Our study provides insights into the clinical profile and health-related quality of life of patients with hydrocephalus caused by MMA. Those with severe hydrocephalus had lower PedsQL™ scores and need surgery. The optimal timing for surgery in these patients is Evans index >0.45, duration of drug treatment >1 month, and age of surgical treatment >4.5 months after birth to reduce surgical complications and improve quality of life.
引用
- Zhou F, Huo Y, Li Y, et al. Hydrocephalus Caused by Methylmalonic Acidemia: Clinical Characteristics, Optimal Timing of Surgical Intervention and Health-Related Quality of Life. Neurosurgery. 2025. PMID: 40539818. doi:10.1227/neu.0000000000003584
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。